- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/02 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ringAlkylene-bis-isoquinolines
Patent holdings for IPC class C07D 217/02
Total number of patents in this class: 393
10-year publication summary
|
25
|
31
|
20
|
30
|
28
|
20
|
21
|
23
|
11
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alcon, Inc. | 5824 |
30 |
| Bausch + Lomb Ireland Limited | 747 |
9 |
| Pfizer Inc. | 3380 |
7 |
| Centre National de La Recherche Scientifique | 11010 |
7 |
| D. Western Therapeutics Institute, Inc. | 20 |
7 |
| Universite de Montpellier | 1040 |
7 |
| Janssen Pharmaceutica N.V. | 3175 |
5 |
| Abivax | 119 |
5 |
| Institut Curie | 615 |
5 |
| SpecGx LLC | 186 |
5 |
| Bristol-myers Squibb Company | 4725 |
4 |
| The Regents of the University of California | 20694 |
4 |
| Merck Patent GmbH | 5725 |
4 |
| Aerie Pharmaceuticals, Inc. | 38 |
4 |
| Alcon, Inc. | 349 |
4 |
| Epizyme, Inc. | 359 |
4 |
| Icahn School of Medicine at Mount Sinai | 1026 |
4 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 178 |
4 |
| The University of Queensland | 663 |
4 |
| Gliapharm SA | 19 |
4 |
| Other owners | 266 |